Annals of Allergy, Asthma & Immunology, 2022
Lower viral loads in subjects with rhinovirus-challenged allergy despite reduced innate immunity

Feng X., Lawrence M., Payne S. et al.

Clinical Cardiology, 2022
Proteomic differences among patients with heart failure taking furosemide or torsemide

Cooper L., Bruce S., Psotka M. et al.

Journal of Allergy and Clinical Immunology, 2022
Altered leukocyte subsets and immune proteome indicate proinflammatory mechanisms in mastocytosis

Hermans M., Heeringa J., Swagemakers S. et al.

Frontiers in Oncology, 2022
A Linear Discriminant Analysis Model Based on the Changes of 7 Proteins in Plasma Predicts Response to Anlotinib Therapy in Advanced Non-Small Cell Lung Cancer Patients

Xu F., Xu H., Wan Z. et al.

International Journal of Molecular Sciences, 2022
IL-17 Pathway Members as Potential Biomarkers of Effective Systemic Treatment and Cardiovascular Disease in Patients with Moderate-to-Severe Psoriasis

Wang X., Kaiser H., Kvist-Hansen A. et al.

European Journal of Heart Failure, 2022
Pathophysiological pathways related to high plasma growth differentiation factor 15 concentrations in patients with heart failure

Ceelen D., Voors A., Tromp J. et al.

Cell Reports Medicine, 2022
Four groups of type 2 diabetes contribute to the etiological and clinical heterogeneity in newly diagnosed individuals: An IMI DIRECT study

Wesolowska-Andersen A., Brorsson C., Bizzotto R. et al.

British Journal of Dermatology, 2022
Janus kinase 1 inhibitor INCB054707 for patients with moderate‐to‐severe hidradenitis suppurativa: results from two phase II studies*

Alavi A., Hamzavi I., Brown K. et al.

International Journal of Epidemiology, 2021
Circulating proteins and risk of pancreatic cancer: a case-subcohort study among Chinese adults

Kartsonaki C., Pang Y., Millwood I. et al.

Journal of Cardiac Failure, 2021
Insulin Growth Factor Phenotypes in Heart Failure With Preserved Ejection Fraction, an INSPIRE Registry and CATHGEN Study

Haddad F., Ataam J., Amsallem M. et al.

Hemodialysis International, 2021
Multiplex proteomics as risk predictor of infection in patients treated with hemodialysis—A prospective multicenter study

Glerup R., Svensson M., Jakobsen L. et al.

Pediatric Rheumatology, 2021
Immunoprofiling of active and inactive systemic juvenile idiopathic arthritis reveals distinct biomarkers: a single-center study

Qu H., Sundberg E., Aulin C. et al.

Frontiers in Neurology, 2021
Putative Concussion Biomarkers Identified in Adolescent Male Athletes Using Targeted Plasma Proteomics

Miller M., Robinson M., Fischer L. et al.

Mucosal Immunology, 2021
Disruption of monocyte-macrophage differentiation and trafficking by a heme analog during active inflammation

Schaefer R., Callahan R., Atif S. et al.

Cancers, 2021
Identification of Potential Prognostic and Predictive Immunological Biomarkers in Patients with Stage I and Stage III Non-Small Cell Lung Cancer (NSCLC): A Prospective Exploratory Study

Vaes R., Reynders K., Sprooten J. et al.

Nature Medicine, 2021
Neurocognitive and hypokinetic movement disorder with features of parkinsonism after BCMA-targeting CAR-T cell therapy

Van Oekelen O., Aleman A., Upadhyaya B. et al.

Mediators of Inflammation, 2021
Butyrate Inhibits Osteoclast Activity In Vitro and Regulates Systemic Inflammation and Bone Healing in a Murine Osteotomy Model Compared to Antibiotic-Treated Mice

Wallimann A., Magrath W., Pugliese B. et al.

Nature Communications, 2021
Proteomic profiling of MIS-C patients indicates heterogeneity relating to interferon gamma dysregulation and vascular endothelial dysfunction

Diorio C., Shraim R., Vella L. et al.

American Journal of Respiratory and Critical Care Medicine, 2021
Alveolar, Endothelial, and Organ Injury Marker Dynamics in Severe COVID-19

Leisman D., Mehta A., Thompson B. et al.

Science Advances, 2021
Causal effects of inflammatory protein biomarkers on inflammatory diseases

Ek W., Karlsson T., Höglund J. et al.